Ramtohul T, Lepagney V, Bonneau C, Jin M, et al. Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy. Radiology 2024;312:e240575.
PMID: 39225608